comparemela.com

Latest Breaking News On - Elizabetho day - Page 1 : comparemela.com

Olaris, Inc. debuts novel global QqQ LC mass spectrometry panel for clinical metabolomics applications at the American Society for Mass Spectrometry 2023 Meeting

Framingham, MA (PRWEB) June 05, 2023 Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning to discover and develop its

United-states
Houston
Texas
American
Jurre-kamphorst
Polaris-inc
American-society-for-mass-spectrometry
Ims-technology
American-society
Mass-spectrometry
Elizabetho-day
Comprehensive-early-responsive-evaluation

Olaris, Inc. to present data on metabolomic changes observed during DCD heart perfusion prior to successful transplant at the American Transplant Congress 2023 Meeting

Framingham, MA (PRWEB) June 05, 2023 Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning to discover and develop its

Massachusetts
United-states
San-diego
California
Framingham
American
Americans
Seyed-alireza-rabi
Asishana-osho
David-dalessandro
American-transplant-congress
Polaris-inc

Olaris Grows Leadership Team with Appointment of Dr. Stuart Chaffee as Executive Chairman

Framingham, MA (PRWEB) September 26, 2022 Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning for the discovery and

Stuart-chaffee
Yale-university
Amgen
Polaris-inc
Glaxosmithkline
College-of-william
Affinivax-inc
Atlas-venture
Wharton-school
University-of-pennsylvania
Elizabetho-day

Olaris, Inc. to present novel myOLARIS™-KTdx assay detecting graft status in kidney transplant recipients at American Transplant Congress 2022 Meeting

Framingham, Massachusetts (PRWEB) June 06, 2022 Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning for the discovery

Boston
Massachusetts
United-states
Framingham
American
Dirk-kuypers
Polaris-inc
Laboratory-of-nephrology
American-transplant-congress
University-of-leuven
International-transplant-science
Elizabetho-day

Olaris, Inc to present non-invasive metabolic signature to detect over-immunosuppression in kidney transplant patients at International Transplant Science 2022 Meeting

Framingham, MA (PRWEB) May 12, 2022 Olaris, Inc, a precision medicine company leveraging metabolomics and machine learning for the discovery and

Germany
Berlin
Dirk-kuypers
Polaris-inc
Laboratory-of-nephrology
University-of-leuven
International-transplant-science
Elizabetho-day
Comprehensive-early-responsive-evaluation
Biomarkers-related
Press-release

vimarsana © 2020. All Rights Reserved.